Keiko Shoji

909 citations

20 papers · 657 indexed · h-index 10

Co-authors: Katsutoshi Oda Hiroyuki Kuramoto M. Sugano Koji Yamada Frank McCormick Yuji Taketani Shunsuke Nakagawa Kei Kawana
Topics: PI3K/AKT/mTOR signaling in cancer (6 papers)Viral gastroenteritis research and epidemiology (2 papers)Virus-based gene therapy research (2 papers)
Cited by: Obstetrics and Gynecology Reproductive Medicine Biochemistry
Journals: Journal of the American Chemical Society Journal of Clinical Oncology PLoS ONE
Partner nations: Japan United States Italy

In The Last Decade

Keiko Shoji

20 papers receiving 644 citations

Peers

Countries citing papers authored by Keiko Shoji

Since Specialization

Citations

This map shows the geographic impact of Keiko Shoji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Shoji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Shoji more than expected).

Fields of papers citing papers by Keiko Shoji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Shoji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Shoji. The network helps show where Keiko Shoji may publish in the future.

Co-authorship network of co-authors of Keiko Shoji

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Shoji. A scholar is included among the top collaborators of Keiko Shoji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Shoji. Keiko Shoji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Attempt to Grasp Resonance during Co-Creation with Biosignal Indicators 2022 ·Proceedings of the Design Society ·(unknown),Keiko Shoji,Yoshinobu Motomura	1
2	Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas 2012 ·PLoS ONE ·Keiko Shoji,Katsutoshi Oda,Tomoko Kashiyama,Yuji Ikeda,Shunsuke Nakagawa,Kenbun Sone,Yuichiro Miyamoto,Haruko Hiraike,Michihiro Tanikawa,Aki Miyasaka,(unknown),Yōko Matsumoto,Osamu Wada‐Hiraike,Kei Kawana,Hiroyuki Kuramoto,Frank McCormick,Hiroyuki Aburatani,Tetsu Yano,Shiro Kōzuma,Yuji Taketani	63
3	Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review 2011 ·Clinical Nephrology ·Keiko Shoji,Hiroyuki Morita,Yasushi Ishigaki,Christopher J. Rivard,(unknown),Kazuhisa Nakayama,Tojo Nakayama,Yuji Inoue,Masako Ayaki,Akira Yoshimura	7
4	Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas. 2011 ·Journal of Clinical Oncology ·Katsutoshi Oda,Keiko Shoji,Setsuko Nakagawa,Tomoko Kashiyama,Yuji Ikeda,Y Miyamoto,Michihiro Tanikawa,Hiroyuki Kuramoto,Masakazu Nishida,(unknown),T. Yano,S. Kozuma,Y. Taketani	6
5	Abstract 4494: In vivo antitumor activity of NVP-BEZ235, a dual PI3K/mTOR inhibitor, and RAD001 (everolimus), an mTOR inhibitor, in endometrial cancer 2011 ·Cancer Research ·Keiko Shoji,Katsutoshi Oda,Shunsuke Nakagawa,Yuji Ikeda,Tomoko Kashiyama,Yuichiro Miyamoto,Michihiro Tanikawa,Hiroyuki Kuramoto,Osamu Wada‐Hiraike,Tetsu Yano,Yuji Taketani	2
6	Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report 2010 ·Medical Oncology ·Keiko Shoji,Katsutoshi Oda,Shunsuke Nakagawa,Kei Kawana,Toshiharu Yasugi,Yuji Ikeda,Yutaka Takazawa,Shiro Kōzuma,Yuji Taketani	20
7	Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway 2010 ·Oncogene ·(unknown),Katsutoshi Oda,Shunsuke Nakagawa,Shumpei Ishikawa,Shogo Yamamoto,Keiko Shoji,Yuji Ikeda,Yuriko Uehara,Masashi Fukayama,Frank McCormick,T. Yano,Y. Taketani,Hiroyuki Aburatani	33
8	Activity of dual PI3K/mTOR inhibitor, NVP-BEZ235, and mTOR inhibitor, RAD001 (everolimus), in endometrial cancer cell lines. 2010 ·Journal of Clinical Oncology ·Keiko Shoji,Katsutoshi Oda,Setsuko Nakagawa,Yuji Ikeda,Hiroyuki Kuramoto,Masakazu Nishida,Kei Kawana,T. Yano,S. Kozuma,Y. Taketani	4
9	The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas 2009 ·British Journal of Cancer ·Keiko Shoji,Katsutoshi Oda,Shunsuke Nakagawa,(unknown),Genta Nagae,Yuriko Uehara,Kenbun Sone,Y Miyamoto,Haruko Hiraike,(unknown),(unknown),Kei Kawana,Hiroyuki Kuramoto,Hiroyuki Aburatani,T. Yano,Y. Taketani	119
10	Reply: Somatic mutations are present in all members of the AKT family in endometrial carcinoma 2009 ·British Journal of Cancer ·Keiko Shoji,Katsutoshi Oda,Shunsuke Nakagawa,(unknown),Genta Nagae,Yuriko Uehara,Kenbun Sone,Y Miyamoto,Haruko Hiraike,(unknown),(unknown),Kei Kawana,Hiroyuki Kuramoto,Hiroyuki Aburatani,T. Yano,Y. Taketani	3
11	PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic Transformation 2008 ·Cancer Research ·Katsutoshi Oda,(unknown),Luika Timmerman,Pablo Rodriguez‐Viciana,David Stokoe,Keiko Shoji,Yuji Taketani,Hiroyuki Kuramoto,Zachary A. Knight,Kevan M. Shokat,Frank McCormick	136
12	Aqueous Extract of Arbutus unedo Inhibits STAT1 Activation in Human Breast Cancer Cell Line MDA-MB-231 and Human Fibroblasts Through SHP2 Activation 2008 ·Medicinal Chemistry ·Sofia Mariotto,A. S. Ciampa,(unknown),Elena Darra,Simone Vincenzi,(unknown),Elisabetta Cavalieri,Keiko Shoji,Hisanori Suzuki	11
13	Salinity Stress Affects Assimilate Metabolism at the Gene-expression Level during Fruit Development and Improves Fruit Quality in Tomato (Solanum lycopersicum L.) 2008 ·Journal of the Japanese Society for Horticultural Science ·Takeshi Saito,Chiaki Matsukura,Yusuke Ban,Keiko Shoji,Masaki Sugiyama,Naoya Fukuda,Shigeo Nishimura	67
14	Effects of Diacylglycerol Oil on Adiposity in Obese Children: Initial Communication 2006 ·Journal of Pediatric Endocrinology and Metabolism ·T. Matsuyama,Keiko Shoji,Hiroyuki Watanabe,Masao Shimizu,(unknown),(unknown),(unknown),Tadashi Hase,Ichiro Tokimitsu,Noriaki Nakaya	9
15	Stomach-Selective Gene Transfer Following the Administration of Naked Plasmid DNA onto the Gastric Serosal Surface in Mice 2006 ·Biological and Pharmaceutical Bulletin ·Junzo Nakamura,Shintaro Fumoto,Keiko Shoji,Yukinobu Kodama,(unknown),Mikiro Nakashima,Hitoshi Sasaki,Koyo Nishida	12
16	Synthesis and hybridization properties ofl-oligodeoxynucleotide analogues fixed in a low anti glycosyl conformation 2004 ·Organic & Biomolecular Chemistry ·Hidehito Urata,(unknown),(unknown),(unknown),Keiji Mori,Keiko Shoji,Keigo Gohda,Masao Akagi	6
17	Liver- and lobe-selective gene transfection following the instillation of plasmid DNA to the liver surface in mice 2002 ·Biochemical and Biophysical Research Communications ·Shigeru Kawakami,(unknown),Keiko Shoji,(unknown),Koyo Nishida,Mikiro Nakashima,Hitoshi Sasaki,Toshiyuki Sakaeda,Junzo Nakamura	27
18	Basis for the Right-Handed Helical Sense of Double-Stranded DNA: Formation of the Right-Handed Helix by l-Oligonucleotides Fixed in Low-anti Glycosyl Conformation 2001 ·Journal of the American Chemical Society ·Hidehito Urata,(unknown),(unknown),Keiji Mori,Keiko Shoji,Masao Akagi	9
19	Effect of tea polyphenols on histamine release from rat basophilic leukemia (RBL‐2H3) cells: the structure–inhibitory activity relationship 1997 ·Allergy ·(unknown),Koji Yamada,Keiko Shoji,(unknown),M. Sugano	119
20	Simulation on Sedimentation of CO2 in Deep Sea. 1996 ·KAGAKU KOGAKU RONBUNSHU ·Akira Saji,Hidetomo Noda,(unknown),Hiroshi Kawata,(unknown),Keiko Shoji,(unknown),(unknown)	3

About Keiko Shoji

Keiko Shoji is a scholar working on Genetics, Biochemistry and Molecular Biology, having authored 20 papers that have together received 657 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Viral gastroenteritis research and epidemiology (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Obstetrics and Gynecology (95 citations), Reproductive Medicine (87 citations) and Biochemistry (52 citations). Keiko Shoji has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Katsutoshi Oda, Hiroyuki Kuramoto, M. Sugano, Koji Yamada, Frank McCormick, Yuji Taketani, Shunsuke Nakagawa, Kei Kawana, Hiroyuki Aburatani and David Stokoe. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact